Symbol
CHRS on Nasdaq
Investment type
Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned
7,602,708 shares
Security Ownership %
6.5%

Evgeny Zaytsev ("Zaytsev") ownership in Coherus Oncology, Inc. Common Stock, par value $0.0001 per share (CHRS)

04 Nov 2025 - Evgeny Zaytsev ("Zaytsev") has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 7,602,708 shares of Coherus Oncology, Inc. Common Stock, par value $0.0001 per share (CHRS). This represents 6.5% ownership of the company. This is the first filing by Bering Partners II, L.P. disclosing ownership of Coherus Oncology, Inc. Common Stock, par value $0.0001 per share (CHRS).